This study examined the prevalence and factors associated with fear of cancer recurrence (FCR) in young adults (YAs).
YAs diagnosed with cancer between the ages of 15 and 39 in Canada (n = 461), who were currently 19 years or older, completed the Young Adults with Cancer in their Prime (YACPRIME) Study. The Fear of Cancer Recurrence Inventory Short Form (FCRI-SF) was the primary outcome. Scores ≥ 16 on the FCRI-SF indicate problematic levels and scores ≥ 22 represent clinically significant FCR. Covariates included demographic, clinical cancer variables, and co-morbid symptom measures. Univariate and multivariate logistic regression analyses were performed to identify variables associated with FCR.
Participants were predominantly female (87%) with a mean age of 32 years (SD = 4.7). Problematic levels of FCR were present in 84% of YAs, and 59% met or exceeded the cutoff for clinically significant FCR. In the multivariate model, time since diagnosis of 5+ years was associated with a reduced likelihood of clinical FCR (Adjusted Odds Ratio [AOR] = 0.354; p = .004), while having a previous recurrence was related to increased likelihood (AOR = 3.468, p = .001). Other factors associated with clinical FCR in YAs were psychological distress (Mild: AOR = 2.947, p = .003; Moderate: AOR = 5.632, p < .0005; Severe: AOR = 8.877, p < .0005), and cancer-related body image dissatisfaction (AOR = 2.311, p = .004).
FCR is a pervasive problem for YAs diagnosed with cancer, with previous recurrence and psychological difficulties as factors associated with a higher degree of fear.
Psychosocial interventions for YAs targeting depression and anxiety should also prioritize the treatment of FCR.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Keegan THM, Ries LAG, Barr RD, Geiger AM, Dahlke DV, Pollock BH, et al. Comparison of cancer survival trends in the United States of adolescents and young adults with those in children and older adults. Cancer. 2016;122(7):1009–16.
Aubin S, Barr R, Rogers P, Schacter B, Bielack SS, Ferrari A, et al. What should the age range by for AYA oncology. J Adolesc Young Adult Oncol. 2011;1:3–10.
Group., A.a.Y.A.O.P.R. Closing the gap: research and cancer care imperatives for adolescents and young adults with cancer. Bethesda, Editor: N.I.o.H.N.C.I.a.t.L.Y.A.A. Department of Health and Human Services; 2006.
Martens T, Rotermund R, zu Eulenburg C, Westphal M, Flitsch J. Long-term follow-up and quality of life in patients with intracranial germinoma. Neurosurg Rev. 2014;37(3):445–50 discussion 451.
Fitch M, et al. Experiences of adult cancer survivors in transitions. Support Care Cancer. 2019;27(8)2977–86.
Lebel S, et al. From normal response to clinical problem: definition and clinical features of fear of cancer recurrence. Support Care Cancer. 2016;24(8):3265–8.
Hanprasertpong J, Geater A, Jiamset I, Padungkul L, Hirunkajonpan P, Songhong N. Fear of cancer recurrence and its predictors among cervical cancer survivors. J Gynecol Oncol. 2017;28(6):e72.
Petzel MQ, et al. Fear of cancer recurrence after curative pancreatectomy: a cross-sectional study in survivors of pancreatic and periampullary tumors. Ann Surg Oncol. 2012;19(13):4078–84.
Thewes B, Bell ML, Butow P. Fear of cancer recurrence in young early-stage breast cancer survivors: the role of metacognitive style and disease-related factors. Psychooncology. 2013;22(9):2059–63.
van de Wal M, van de Poll-Franse L, Prins J, Gielissen M. Does fear of cancer recurrence differ between cancer types? A study from the population-based PROFILES registry. Psychooncology. 2016;25(7):772–8.
Hedman C, Strang P, Djärv T, Widberg I, Lundgren CI. Anxiety and fear of recurrence despite a good prognosis: an interview study with differentiated thyroid cancer patients. Thyroid. 2017;27(11):1417–23.
Mehnert A, Koch U, Sundermann C, Dinkel A. Predictors of fear of recurrence in patients one year after cancer rehabilitation: a prospective study. Acta Oncol. 2013;52(6):1102–9.
Savard J, Ivers H. The evolution of fear of cancer recurrence during the cancer care trajectory and its relationship with cancer characteristics. J Psychosom Res. 2013;74(4):354–60.
Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013;7(3):300–22.
Shay LA, Carpentier MY, Vernon SW. Prevalence and correlates of fear of recurrence among adolescent and young adult versus older adult post-treatment cancer survivors. Support Care Cancer. 2016;24(11):4689–96.
Lebel S, Tomei C, Feldstain A, Beattie S, McCallum M. Does fear of cancer recurrence predict cancer survivors' health care use? Support Care Cancer. 2013;21(3):901–6.
Mehnert A, Berg P, Henrich G, Herschbach P. Fear of cancer progression and cancer-related intrusive cognitions in breast cancer survivors. Psycho-Oncology. 2009;18(12):1273–80.
Jorngarden A, Mattsson E, von Essen L. Health-related quality of life, anxiety and depression among adolescents and young adults with cancer: a prospective longitudinal study. Eur J Cancer. 2007;43(13):1952–8.
Seitz DC, et al. Posttraumatic stress, depression and anxiety among adult long-term survivors of cancer in adolescence. Eur J Cancer. 2010;46(9):1596–606.
Lebel S, Beattie S, Arès I, Bielajew C. Young and worried: age and fear of recurrence in breast cancer survivors. Health Psychol. 2013;32(6):695–705.
Ness S, Kokal J, Fee-Schroeder K, Novotny P, Satele D, Barton D. Concerns across the survivorship trajectory: results from a survey of cancer survivors. Oncol Nurs Forum. 2013;40:35–42.
Berrett-Abebe J, Cadet T, Pirl W, Lennes I. Exploring the relationship between fear of cancer recurrence and sleep quality in cancer survivors. J Psychosoc Oncol. 2015;33(3):297–309.
Barnett M, McDonnell G, DeRosa A, Schuler T, Philip E, Peterson L, et al. Psychosocial outcomes and interventions among cancer survivors diagnosed during adolescence and young adulthood (AYA): a systematic review. J Cancer Surviv. 2016;10(5):814–31.
Bellizzi KM, Smith A, Schmidt S, Keegan THM, Zebrack B, Lynch CF, et al. Positive and negative psychosocial impact of being diagnosed with cancer as an adolescent or young adult. Cancer. 2012;118(20):5155–62.
D'Agostino NM, Edelstein K. Psychosocial challenges and resource needs of young adult cancer survivors: implications for program development. J Psychosoc Oncol. 2013;31(6):585–600.
Epelman CL. The adolescent and young adult with cancer: state of the art -- psychosocial aspects. Curr Oncol Rep. 2013;15(4):325–31.
Zebrack B, Kwak M, Salsman J, Cousino M, Meeske K, Aguilar C, et al. The relationship between posttraumatic stress and posttraumatic growth among adolescent and young adult (AYA) cancer patients. Psychooncology. 2015;24(2):162–8.
Eom CS, Shin DW, Kim SY, Yang HK, Jo HS, Kweon SS, et al. Impact of perceived social support on the mental health and health-related quality of life in cancer patients: results from a nationwide, multicenter survey in South Korea. Psychooncology. 2013;22(6):1283–90.
Yang Y, Li W, Wen Y, Wang H, Sun H, Liang W, et al. Fear of cancer recurrence in adolescent and young adult cancer survivors: a systematic review of the literature. Psycho-Oncology. 2019;28(4):675–86.
Thewes B, et al. Prevalence and correlates of high fear of cancer recurrence in late adolescents and young adults consulting a specialist adolescent and young adult (AYA) cancer service. Support Care Cancer. 2018;26(5):1479–87.
Sun H, Yang Y, Zhang J, Liu T, Wang H, Garg S, et al. Fear of cancer recurrence, anxiety and depressive symptoms in adolescent and young adult cancer patients. Neuropsychiatr Dis Treat. 2019;15:857–65.
Simard S, Savard J. Screening and comorbidity of clinical levels of fear of cancer recurrence. J Cancer Surviv. 2015;9(3):481–91.
Simard S, Savard J. Fear of Cancer recurrence inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2009;17(3):241–51.
Fardell JE, Jones G, Smith AB, Lebel S, Thewes B, Costa D, et al. Exploring the screening capacity of the fear of cancer recurrence inventory-short form for clinical levels of fear of cancer recurrence. Psychooncology. 2018;27(2):492–9.
Kessler RC, Andrews G, Colpe LJ, Hiripi E, Mroczek DK, Normand S-LT, et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med. 2002;32:959–76.
Andrews G, Slade T. Interpreting scores on the Kessler Psychological Distress Scale (K10). Aust N Z J Public Health. 2001;25(6):494–7.
McCarthy MC, McNeil R, Drew S, Dunt D, Kosola S, Orme L, et al. Psychological distress and posttraumatic stress symptoms in adolescents and young adults with cancer and their parents. J Adolesc Young Adult Oncol. 2016;5(4):322–9.
Ware JE, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33.
Smith AW, Bellizzi KM, Keegan THM, Zebrack B, Chen VW, Neale AV, et al. Health-related quality of life of adolescent and young adult patients with cancer in the United States: the adolescent and young adult health outcomes and patient experience study. J Clin Oncol. 2013;31(17):2136–45.
Maruish ME, editor. User’s manual for the SF-12v2 Health Survey. Lincoln, RI: QualityMetric Incorporated; 2012. p. 324.
Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213.
Beck SL, Schwartz AL, Towsley G, Dudley W, Barsevick A. Psychometric evaluation of the Pittsburgh Sleep Quality Index in cancer patients. J Pain Symptom Manag. 2004;27(2):140–8.
Daniel L, Kazak AE, Li Y, Hobbie W, Ginsberg J, Butler E, et al. Relationship between sleep problems and psychological outcomes in adolescent and young adult cancer survivors and controls. Support Care Cancer. 2016;24(2):539–46.
Cordova MJ, Cunningham LLC, Carlson CR, Andrykowski MA. Posttraumatic growth following breast cancer: a controlled comparison study. Health Psychol. 2001;20(3):176–85.
Holtmaat K, van der Spek N, Cuijpers P, Leemans CR, Verdonck-de Leeuw IM. Posttraumatic growth among head and neck cancer survivors with psychological distress. Psychooncology. 2017;26(1):96–101.
Jansen L, Hoffmeister M, Chang-Claude J, Brenner H, Arndt V. Benefit finding and post-traumatic growth in long-term colorectal cancer survivors: prevalence, determinants, and associations with quality of life. Br J Cancer. 2011;105(8):1158–65.
Tedeschi RG, Calhoun LG. The posttraumatic growth inventory: measuring the positive legacy of trauma. J Trauma Stress. 1996:9(3).
Hopwood P, Fletcher I, Lee A, Ghazal SA. A body image scale for use with cancer patients. Eur J Cancer. 2001;37:189–97.
Falk Dahl CA, Reinertsen KV, Nesvold IL, Fosså SD, Dahl AA. A study of body image in long-term breast cancer survivors. Cancer. 2010;116(15):3549–57.
Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991;32(6):705–14.
Priede A, Andreu Y, Martínez P, Conchado A, Ruiz-Torres M, González-Blanch C. The factor structure of the medical outcomes study-social support survey: a comparison of different models in a sample of recently diagnosed cancer patients. J Psychosom Res. 2018;108:32–8.
Dong J, Peng CY. Principled missing data methods for researchers. Springerplus. 2013;2(1):e222.
Bartlett JW, Harel O, Carpenter JR. Asymptotically unbiased estimation of exposure odds ratios in complete records logistic regression. Am J Epidemiol. 2015;182(8):730–6.
Statistical tutorials and software guides 2017 Binomial logistic regression using SPSS Statistics. Available from: https://statistics.laerd.com/. Accessed 19 July 2019.
Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code Biol Med. 2008;3:17.
Nagelkerke NJD. A note on a general definition of the coefficient of determination. Biometrika. 1991;78(3):691–2.
Koch L, Jansen L, Brenner H, Arndt V. Fear of recurrence and disease progression in long-term (>/= 5 years) cancer survivors--a systematic review of quantitative studies. Psychooncology. 2013;22(1):1–11.
Crist JV, Grunfeld EA. Factors reported to influence fear of recurrence in cancer patients: a systematic review. Psycho-Oncology. 2013;22(5):978–86.
Understanding statistics used to guide prognosis and evaluate treatment. 2016 [cited 2018 July 30]; Available from: https://www.cancer.net/navigating-cancer-care/cancer-basics/understanding-statistics-used-guide-prognosis-and-evaluate-treatment. Accessed 30 July 2018.
Lichtenthal WG, Corner GW, Slivjak ET, Roberts KE, Li Y, Breitbart W, et al. A pilot randomized controlled trial of cognitive bias modification to reduce fear of breast cancer recurrence. Cancer. 2017;123(8):1424–33.
Rippetoe PA, Rogers RW. The effects of components of protection-motivation theory on adaptive and maladaptive coping with a health treatment. Pers Soc Psychol. 1987;52:596–604.
Fardell JE, Thewes B, Turner J, Gilchrist J, Sharpe L, Smith A‘B’, et al. Fear of cancer recurrence: a theoretical review and novel cognitive processing formulation. J Cancer Surviv. 2016;10(4):663–73.
Liu J, Peh CX, Simard S, Griva K, Mahendran R. Beyond the fear that lingers: the interaction between fear of cancer recurrence and rumination in relation to depression and anxiety symptoms. J Psychosom Res. 2018;111:120–6.
Nolen-Hoeksema S. The role of rumination in depressive disorders and mixed/anxiety/depressive symptoms. J Abnorm Psychol. 2000;109(3):504–11.
Humphris GM, Rogers S, McNally D, Lee-Jones C, Brown J, Vaughan D. Fear of recurrence and possible cases of anxiety and depression in orofacial cancer patients. Int J Oral Maxillofac Surg. 2003;32:486–91.
Simonelli LE, Siegel SD, Duffy NM. Fear of cancer recurrence: a theoretical review and its relevance for clinical presentation and management. Psychooncology. 2017;26(10):1444–54.
Mutsaers B, Jones G, Rutkowski N, Tomei C, Séguin Leclair C, Petricone-Westwood D, et al. When fear of cancer recurrence becomes a clinical issue: a qualitative analysis of features associated with clinical fear of cancer recurrence. Support Care Cancer. 2016;24(10):4207–18.
We gratefully acknowledge the contributions of all the young adults with cancer across Canada who participated in the study.
This study was supported by a patient-oriented research grant from the Newfoundland and Labrador Support for People and Person Oriented Research and Trials (NL SUPPORT) unit. Breanna Lane is funded by a doctoral award from the Translational and Personalized Medicine Initiative/NL SUPPORT Unit. Dr. Sheila Garland is funded by a Beatrice Hunter Cancer Research Institute and Scotiabank New Investigator Award.
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the Interdisciplinary Committee on Ethics in Human Research (ICEHR) at Memorial University.
All participants provided informed consent as outlined in the digital consent form and were provided with debriefing information upon completion.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Lane, B.E., Garland, S.N., Chalifour, K. et al. Prevalence and factors associated with fear of recurrence in a mixed sample of young adults with cancer. J Cancer Surviv 13, 842–851 (2019). https://doi.org/10.1007/s11764-019-00802-9